A detailed history of Aqr Capital Management LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 113,725 shares of CRBU stock, worth $189,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,725
Previous 18,341 520.06%
Holding current value
$189,920
Previous $30,000 636.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.56 - $2.73 $148,799 - $260,398
95,384 Added 520.06%
113,725 $221,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $29,712 - $92,622
18,341 New
18,341 $30,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $102M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.